David Shook - Jan 16, 2024 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Medical Officer
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Stock symbol
NKTX
Transactions as of
Jan 16, 2024
Transactions value $
-$31,044
Form type
4
Date filed
1/18/2024, 04:45 PM
Previous filing
Jan 8, 2024
Next filing
Jun 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Sale -$31K -3.55K -3% $8.74 115K Jan 16, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $8.74 to $8.96. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.